The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Francesco Ingenito, Giuseppina Roscigno, Alessandra Affinito...
https://pubmed.ncbi.nlm.nih.gov/31546654/Actively Recruiting
Led by City of Hope Medical Center · Updated on 2026-09-28
2000
Participants Needed
13
Research Sites
N/A
Total Duration
Pancreatic ductal adenocarcinoma PDAC is a severe form of cancer that is often detected too late for effective treatment. Current blood markers like serum carbohydrate antigen 19-9 CA19-9 are unreliable for early detection. Researchers developed a method analyzing exosomes containing microRNAs miRNAs to detect early-stage PDAC more accurately. This study aims to confirm this methods effectiveness in a larger international group. The study evaluates a diagnostic test called PANcreatic cancer Exosome Early detectiON PANXEON, which uses qRT-PCR to measure levels of 5 cell-free and 8 exosome miRNAs in blood plasma. Participants include individuals diagnosed with pancreatic ductal adenocarcinoma and those without the disease, divided into training and validation groups. The study is observational and collects plasma samples to assess these miRNA signatures. Participants will provide plasma samples before any curative treatment and undergo standard diagnostic and staging procedures. Researchers will monitor outcomes including the tests sensitivity, specificity, and accuracy over about one year. The study involves individuals with various stages of PDAC and controls without the disease, with ongoing data collection until the study completion date in 2030.
CONDITIONS
Pancreatic Cancer Detection Consortium
A
Ajay Goel, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
City of Hope Medical Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Francesco Ingenito, Giuseppina Roscigno, Alessandra Affinito...
https://pubmed.ncbi.nlm.nih.gov/31546654/Talia Golan, Pascal Hammel, Michele Reni...
https://pubmed.ncbi.nlm.nih.gov/31157963/Klaus Pantel, Catherine Alix-Panabières
https://pubmed.ncbi.nlm.nih.gov/30796368/Kunitoshi Shigeyasu, Shusuke Toden, Timothy J Zumwalt...
https://pubmed.ncbi.nlm.nih.gov/28143873/Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi...
https://pubmed.ncbi.nlm.nih.gov/27265347/Thierry Conroy, Pascal Hammel, Mohamed Hebbar...
https://pubmed.ncbi.nlm.nih.gov/30575490/Lola Rahib, Benjamin D Smith, Rhonda Aizenberg...
https://pubmed.ncbi.nlm.nih.gov/24840647/David P Ryan, Theodore S Hong, Nabeel Bardeesy
https://pubmed.ncbi.nlm.nih.gov/25207767/Daniel D Von Hoff, Thomas Ervin, Francis P Arena...
https://pubmed.ncbi.nlm.nih.gov/24131140/A K Krug, D Enderle, C Karlovich...
https://pubmed.ncbi.nlm.nih.gov/29216356/City of Hope Medical Center
Lead Sponsor